Dual biologic therapy linked with clinical improvements in Crohn’s

Treatment with dual biologic therapy was associated with clinical and endoscopic improvements in patients with Crohn’s disease who previously failed multiple biologics, according to study results.Robert Battat, MD, of the Jill Roberts Center for Inflammatory Bowel Disease at Weill Cornell Medicine, and colleagues wrote that many patients still fail to achieve prolonged clinical remission even with recent improvement to biologic IBD therapies.“Despite the safety of newer biologics, simultaneous treatment with two biologic medications is rarely utilized,” they wrote. “ItRead More

Share on facebook
Share on twitter
Share on linkedin